» Authors » Annelynn Wallaert

Annelynn Wallaert

Explore the profile of Annelynn Wallaert including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 7
Citations 820
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Wallaert A, Van Loocke W, Hernandez L, Taghon T, Speleman F, Van Vlierberghe P
Sci Rep . 2017 Aug; 7(1):7901. PMID: 28801656
T-cell acute lymphoblastic leukemia (T-ALL) is a genetically heterogeneous disease that can be classified into different molecular genetic subtypes according to their mRNA gene expression profile. In this study, we...
2.
Lammens T, Durinck K, Wallaert A, Speleman F, Van Vlierberghe P
Curr Opin Hematol . 2017 Apr; 24(4):353-358. PMID: 28441150
Purpose Of Review: Over the last years, long non-coding RNAs (lncRNAs) have emerged as putative regulators of malignant hematopoietic development. Here, we review recent literature on the involvement of lncRNAs...
3.
Wallaert A, Durinck K, Taghon T, Van Vlierberghe P, Speleman F
J Hematol Oncol . 2017 Mar; 10(1):66. PMID: 28270163
In the last decade, the role for noncoding RNAs in disease was clearly established, starting with microRNAs and later expanded towards long noncoding RNAs. This was also the case for...
4.
Van Deun J, Mestdagh P, Agostinis P, Akay O, Anand S, Anckaert J, et al.
Nat Methods . 2017 Mar; 14(3):228-232. PMID: 28245209
We argue that the field of extracellular vesicle (EV) biology needs more transparent reporting to facilitate interpretation and replication of experiments. To achieve this, we describe EV-TRACK, a crowdsourcing knowledgebase...
5.
Ghazavi F, De Moerloose B, Van Loocke W, Wallaert A, Helsmoortel H, Ferster A, et al.
Oncotarget . 2016 Sep; 7(45):73769-73780. PMID: 27650541
Overwhelming evidence indicates that long non-coding RNAs have essential roles in tumorigenesis. Nevertheless, their role in the molecular pathogenesis of pediatric B-cell precursor acute lymphoblastic leukemia has not been extensively...
6.
Durinck K, Goossens S, Peirs S, Wallaert A, Van Loocke W, Matthijssens F, et al.
Exp Hematol . 2015 Jul; 43(8):625-39. PMID: 26123366
T-cell acute lymphoblastic leukemia (T-ALL) is an aggressive type of blood cancer that accounts for about 15% of pediatric and 25% of adult acute lymphoblastic leukemia (ALL) cases. It is...
7.
Durinck K, Wallaert A, Van de Walle I, Van Loocke W, Volders P, Vanhauwaert S, et al.
Haematologica . 2014 Oct; 99(12):1808-16. PMID: 25344525
Genetic studies in T-cell acute lymphoblastic leukemia have uncovered a remarkable complexity of oncogenic and loss-of-function mutations. Amongst this plethora of genetic changes, NOTCH1 activating mutations stand out as the...